Fingerprint
Dive into the research topics of 'Maintenance infliximab for Crohn's disease: The ACCENT I randomised trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Maintenance infliximab for Crohn's disease: The ACCENT I randomised trial
Stephen B. Hanauer, Brian G. Feagan, Gary R. Lichtenstein, Lloyd F. Mayer, S. Schreiber, Jean Frederic Colombel, Daniel Rachmilewitz, Douglas C. Wolf, Allan Olson, Weihang Bao, Paul Rutgeerts
Research output: Contribution to journal › Article › peer-review
3620
Scopus
citations